Natco Pharma inks pact with Mabxience
Three of these products -Trastuzumab, Bevacizumab, Rituximab belong to the oncology segment, while Etanercept is for auto-immune disease, Natco said in a statement. Natco's obligations under the agreement will include manufacture of drug products, ...
Natco Pharmaceuticals inks pact with Swiss firm Chemo Sa Lugano for purchase ...Economic Times
Natco Pharma Signs Pact With MabxienceRTT News
Natco to enter bio-generics; signs up with MabxienceHindu Business Line

all 20 news articles »